Philips Integrates AI in Cardiac Ultrasound and Across Cardiac Care at ESC 2023

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help improve clinical confidence and increase efficiency. Center-stage at the European Society of Cardiology (ESC, Aug. 25-28, Amsterdam) Congress is the portable Philips Ultrasound Compact System 5500 CV, which includes an AI-powered automation tool (the automated strain quantification) to assess the function of the heart’s left ventricle, a key indicator of heart health.

“The demands on cardiology departments have never been higher, driving clinicians to balance the delivery of high-quality care for a growing volume of complex patients with pressures to improve departmental efficiency,” said Bert van Meurs, Executive Vice President and Chief Business Leader of Image Guided Therapy and Precision Diagnosis at Philips. 

Integrating AI in cardiac ultrasound

Ultrasound is one of the most used imaging modalities as the first line of diagnosis for cardiac patients. A shortage of operators dealing with heavy workloads and growing numbers of complex cases continues to challenge health systems across the globe. Using AI to help streamline workflows and enhance diagnostic confidence is core to Philips cardiac ultrasound technology. Each year, Philips’ ultrasound systems support the diagnosis and treatment of more than 240 million patients.

Philips is a leader in integrating AI-powered technology across its cardiac ultrasound portfolio, including full 3D quantification and modeling of the heart, automated 2D Doppler and length measurements, reproducible 2D strain quantification and dynamic analysis of the mitral valve. The company is now integrating AI-powered automated analysis and reporting.  

Integrating AI across Cardiac Care

Individually, Philips’ solutions can help solve cardiology’s daily challenges. Together, they create a powerful ecosystem that helps clinicians realize better cardiac care with greater efficiency. At ESC, Philips will also highlight its Advanced Visualization Workspace, which integrates AI-enabled algorithms and workflows into a single workspace. The integration of Cardiac MR and CT on Philips Advanced Visualization Workspace has lowered overall analysis time by 20-30% [1].

Philips monitors 1.2 million patients every year, with 4 billion heartbeat data transmissions daily [2]. Philips cardiology management solutions include remote cardiac monitoring innovations from Philips ECG Solutions, a leading AI-powered remote ambulatory cardiac monitoring provider, to better manage heart patients by extending physicians’ diagnostics  and cardiac monitoring from home to hospital – and hospital to home.

Visit Philips at ESC (Hall 1, booth #A300) for more information on Philips’ entire program at the event, including a satellite symposium featuring global clinical leaders addressing some of the major challenges in peri-interventional and diagnostic echocardiography and a wide range of hands-on tutorial sessions. Follow @PhilipsLiveFrom for #ESCCongress updates throughout the event. 

[1] Dr. Gaby Weissman, MD MedStar Washington Hospital Center, Washington, D.C., USA
[2] Data on file

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”